Abstract | BACKGROUND/AIMS: METHODS: Forty patients (Child-Pugh class B, 24 patients; Child-Pugh class C, 16 patients) with hydrothorax refractory to diuretic treatment, pleurocenteses or pleurodesis were included. The TIPS implantation was successful in all patients, who were then followed for 16 +/- 14 months (range 1 day-54 months). RESULTS:
TIPS reduced the portosystemic pressure gradient from 26 +/- 6 to 10 +/- 5 mmHg. In the 17 patients whom we followed for 12 months or longer, improvements were found for the Child--Pugh score (8.6 +/- 1.8 v. 6.7 +/- 1.5), serum albumin concentration (3.1 +/- 0.5 v. 3.6 +/- 0.5 g/l), and urinary sodium excretion (22 +/- 29 v. 89 +/- 43 mmol/24 h) (P< 0.05). Two patients developed severe hepatic encephalopathy requiring shunt occlusion. Hydrothorax improved in 82% of patients and resolved in 71% of patients. Fifty per cent of patients developed shunt insufficiency within 7 +/- 9 months, contributing to a probability of relapse-free 1-year survival of 35%. In these patients, shunt revision resulted in a secondary response rate of 82.3%. The 1-year survival was 64%. Both hydrothorax response and survival showed a significant inverse correlation with age over 60 years (P< 0.01 and P< 0.003, respectively) but not with other biomedical variables. CONCLUSION:
TIPS is effective for hydrothorax refractory to diuretic treatment and other standard interventions to bridge the time to transplantation. Patients older than 60 years have a poor response and short survival.
|
Authors | V Siegerstetter, P Deibert, A Ochs, M Olschewski, H E Blum, M Rössle |
Journal | European journal of gastroenterology & hepatology
(Eur J Gastroenterol Hepatol)
Vol. 13
Issue 5
Pg. 529-34
(May 2001)
ISSN: 0954-691X [Print] England |
PMID | 11396532
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Ascites
(complications)
- Diuretics
(therapeutic use)
- Female
- Follow-Up Studies
- Humans
- Hydrothorax
(drug therapy, etiology, metabolism, surgery)
- Male
- Middle Aged
- Portasystemic Shunt, Transjugular Intrahepatic
(methods)
- Recurrence
- Retrospective Studies
- Severity of Illness Index
- Survival Analysis
- Time Factors
- Treatment Outcome
|